肿瘤生物学在结直肠癌肝转移中的预后及治疗意义
Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases.
作者信息
Kamphues Carsten, Beyer Katharina, Margonis Georgios Antonios
机构信息
Department of General and Visceral Surgery, Charité Campus Benjamin Franklin, 12203 Berlin, Germany.
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
出版信息
Cancers (Basel). 2021 Dec 24;14(1):88. doi: 10.3390/cancers14010088.
Abstract
Prognostic models allow clinicians to predict survival outcomes, facilitate patient-physician discussions, and identify subgroups with potentially distinct prognoses [...].
摘要
预后模型使临床医生能够预测生存结果，促进医患沟通，并识别出可能具有不同预后的亚组[……]。
相似文献
1
Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases.肿瘤生物学在结直肠癌肝转移中的预后及治疗意义
Cancers (Basel). 2021 Dec 24;14(1):88. doi: 10.3390/cancers14010088.
2
Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.转移性结直肠癌患者的治疗结果、复苏偏好及医患沟通。SUPPORT研究组。了解治疗结果、风险的预后及偏好的研究。
Am J Med. 1998 Sep;105(3):222-9. doi: 10.1016/s0002-9343(98)00242-3.
3
Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.肿瘤浸润淋巴细胞密度在结直肠癌肝转移中的预后价值
Oncol Lett. 2021 Dec;22(6):837. doi: 10.3892/ol.2021.13098. Epub 2021 Oct 18.
4
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].[结直肠癌肝转移肝切除术后长期预后的预后因素]
Chir Ital. 2005 Sep-Oct;57(5):555-70.
5
Prognostic Factors after Liver Resection for Colorectal Liver Metastasis.结直肠癌肝转移肝切除术后的预后因素
Acta Med Port. 2015 May-Jun;28(3):357-69. doi: 10.20344/amp.4816. Epub 2015 Jun 30.
6
Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer.结直肠癌肝转移冷冻治疗后的预后因素。
Ann Surg. 1998 Aug;228(2):201-8. doi: 10.1097/00000658-199808000-00009.
7
Prognostic scoring in colorectal cancer liver metastases: development and validation.结直肠癌肝转移的预后评分：开发与验证
Arch Surg. 2005 Feb;140(2):183-9. doi: 10.1001/archsurg.140.2.183.
8
Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC.预测适合减瘤手术和腹腔热灌注化疗的结直肠癌腹膜转移患者生存的有效策略
Cancer Manag Res. 2021 Jul 1;13:5239-5249. doi: 10.2147/CMAR.S277912. eCollection 2021.
9
Liver fatty acid-binding protein is a new prognostic factor for hepatic resection of colorectal cancer metastases.肝脏脂肪酸结合蛋白是结直肠癌肝转移灶肝切除术后的一个新的预后因素。
J Surg Oncol. 1999 Oct;72(2):83-7. doi: 10.1002/(sici)1096-9098(199910)72:2<83::aid-jso8>3.0.co;2-c.
10
Pretreatment echogenicity of colorectal liver metastases predicts survival after hepatic cryotherapy.结直肠肝转移瘤的治疗前回声可预测肝脏冷冻治疗后的生存率。
Dis Colon Rectum. 1999 Jan;42(1):43-9. doi: 10.1007/BF02235181.
引用本文的文献
1
High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy.生物标志物CD44v6/α2β1和CD44v6/PD-L1的高双重表达表明结直肠癌肝转移切除术后早期复发。
Cancers (Basel). 2022 Apr 12;14(8):1939. doi: 10.3390/cancers14081939.
本文引用的文献
1
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.mFOLFOX6方案辅助肝切除与单纯肝切除治疗单纯肝转移结直肠癌的比较（JCOG0603）：一项II期或III期随机对照试验
J Clin Oncol. 2021 Dec 1;39(34):3789-3799. doi: 10.1200/JCO.21.01032. Epub 2021 Sep 14.
2
Perioperative chemotherapy versus surgery alone for resectable colorectal liver metastases: an international multicentre propensity score matched analysis on long-term outcomes according to established prognostic risk scores.可切除结直肠肝转移的围手术期化疗与单纯手术治疗：根据既定预后风险评分的国际多中心倾向评分匹配分析长期结果。
HPB (Oxford). 2021 Dec;23(12):1873-1885. doi: 10.1016/j.hpb.2021.04.026. Epub 2021 May 15.
3
Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.用于预测结直肠肝转移切除术后生存的轮廓预后模型：使用最大直径和 RAS 突变状态的转移瘤数量进行的开发和多中心验证研究。
Br J Surg. 2021 Aug 19;108(8):968-975. doi: 10.1093/bjs/znab086.
4
Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.结直肠癌肝转移灶切除术：肿瘤负荷与KRAS突变状态对预后的影响
J Am Coll Surg. 2021 Apr;232(4):590-598. doi: 10.1016/j.jamcollsurg.2020.11.023. Epub 2020 Dec 28.
5
The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions.同步性结直肠癌肝转移患者中原发肿瘤位置与KRAS突变状态的相互作用：当前数据与未解决的问题
Ann Surg Oncol. 2020 Dec;27(13):4864-4866. doi: 10.1245/s10434-020-09144-8. Epub 2020 Sep 21.
6
First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases.ALPPS 手术治疗结直肠癌肝转移的大型队列患者的长期肿瘤学结果。
Ann Surg. 2020 Nov;272(5):793-800. doi: 10.1097/SLA.0000000000004330.
7
Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.预后因素因 KRAS 突变状态而异：一种用于定义结直肠癌肝转移肝切除术后预后分组的分类和回归树模型。
Surgery. 2020 Sep;168(3):497-503. doi: 10.1016/j.surg.2020.05.019. Epub 2020 Jul 13.
8
Coaltered and Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer.在转移性结直肠癌患者中，Coaltered 与生存极限和转移的独特模式相关。
Clin Cancer Res. 2020 Mar 1;26(5):1077-1085. doi: 10.1158/1078-0432.CCR-19-2390. Epub 2019 Nov 12.
9
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.扩展分子谱分析可改善结直肠癌肝转移切除术后的分层和生存预测。
Ann Surg. 2019 Nov;270(5):799-805. doi: 10.1097/SLA.0000000000003527.
10
The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.原发肿瘤部位的预后影响因 KRAS 突变状态而异：国际结直肠癌肝转移遗传协作组的研究。
Ann Surg. 2021 Jun 1;273(6):1165-1172. doi: 10.1097/SLA.0000000000003504.
Zotero 插件